0001062993-16-009883.txt : 20160519 0001062993-16-009883.hdr.sgml : 20160519 20160519114216 ACCESSION NUMBER: 0001062993-16-009883 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160518 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Toby CENTRAL INDEX KEY: 0001405128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 161662351 MAIL ADDRESS: STREET 1: 4092 BOCAIRE BLVD. CITY: BOCA RATON STATE: FL ZIP: 33487 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2016-05-18 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405128 Wegman Toby C/O BIOSPECIFICS TECHNOLOGIES CORP., 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2016-05-18 4 S 0 50 33.8 D 1005128 I See footnote Common Stock, $0.001 par value 2016-05-18 4 S 0 150 34.14 D 1004978 I See footnote Common Stock, $0.001 par value 2016-05-18 4 S 0 50 34.11 D 1004928 I See footnote Common Stock, $0.001 par value 2016-05-18 4 S 0 24750 33 D 980178 I See footnote The selling price of $33.80 is reflective of the sale price of all transactions reported on this line. The selling price of $34.14 is reflective of the sale price of all transactions reported on this line. The selling price of $34.11 is reflective of the sale price of all transactions reported on this line. The selling price of $33.00 is reflective of the sale price of all transactions reported on this line. These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein. /s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman 2016-05-19